ProtoKinetix AAGP® Restores Vision in Blind Test Subjects

by Business Wire • 2020/09/15 • 0 Comments

MARIETTA, Ohio--(BUSINESS WIRE)-- #AAGP--ProtoKinetix AAGP® Restores Vision in Blind Test Subjects

← Phase 2 study of AU-011 for primary choroidal melanoma underway

Aviceda Therapeutics Appoints Biopharma and Business Veterans Chris Adams, PhD, MBA, and Nancy K. Thomason, MBA to its Board of Directors →